Evaluating Ultrasound as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis - Quiz - MDSpire

Evaluating Ultrasound as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis

  • By

  • Qing Feng Shi

  • Peng Fei Hu

  • Yong Hong Liu

  • January 13, 2026

  • 0 min

Share

Original Source(s)

Evaluating Ultrasound as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis

  • by Qing Feng Shi, Peng Fei Hu, Yong Hong Liu

  • January 13, 2026

Related Content

Mesh-free prepectoral breast reconstruction: a safe and effective alternative

Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study

Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit